June 2026 in “Frontiers in Oncology” Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.
April 2026 in “Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi” 37.4% of dermatology theses in Türkiye were published, mainly in high-impact journals, with publication linked to the thesis year.
Higher cortisol levels might be linked to worsening keratoconus.
Researchers developed a cost-effective, ethical skin model using hairless guinea pig cells for toxicology studies.
February 2026 in “Reports — Medical Cases Images and Videos” Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.
February 2026 in “Trials” The study aims to find the best platelet-rich plasma dose to relieve moderate carpal tunnel syndrome symptoms.
January 2026 in “Vestnik dermatologii i venerologii” AI in dermatology shows high accuracy in diagnosing skin diseases but needs more research for improvement.
January 2026 in “Andrology” PRP injections are safe but don't significantly improve Peyronie's Disease.
January 2026 in “Frontiers in Digital Health” Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.
December 2025 in “Drug Design Development and Therapy” Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.
November 2025 in “Turkish Journal of Dermatology” FUE technique offers higher satisfaction and broader use for women needing hair transplants.
November 2025 in “Journal of Dermatological Treatment” Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.
November 2025 in “Figshare” Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.
November 2025 in “Journal of Laboratory Medicine” Chronic stress increased after lockdown, especially in young adults and females.
October 2025 in “Clinical and Experimental Dermatology” Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.
October 2025 in “Frontiers in Endocrinology” Methimazole for hyperthyroidism has known and new side effects needing more study for safety.
August 2025 in “Clinical and Experimental Dermatology” Alopecia areata treatments often don't lead to lasting improvement.
Microneedling with exosome therapy may effectively regrow hair without side effects.
July 2025 in “SKIN The Journal of Cutaneous Medicine” Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.
July 2025 in “Journal of Investigative Dermatology” AI-09 is safe, effective, and reduces wrinkles for up to 6 months.
June 2025 in “British Journal of Dermatology” Patients face long waits and misdiagnoses before getting proper hair loss treatment.
April 2025 in “The Journal of Dermatology” Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.
March 2025 in “JAAD International” Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.
February 2025 in “Archives of Dermatological Research” Combining PRP with topical minoxidil is most effective for hair growth in androgenetic alopecia.
January 2025 in “Dermatology Practical & Conceptual” Perinevoid alopecia can be effectively treated with non-invasive corticosteroids.
January 2025 in “Zagazig University Medical Journal” Nanofat injections may improve hair graft survival in scarred areas.
January 2025 in “Dermatologic Therapy” Minoxidil with betamethasone is the most effective for hair regrowth in alopecia areata.
January 2025 in “Dermatologic Therapy” The laser treatment improved hair appearance and was safe and well-received by patients.
Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.